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Abstract
Background: Hereditary spastic paraplegias (HSPs) are a clinically and genetically heterogeneous group of neurological diseases, which typically present with
progressive lower extremity weakness and spasticity causing progressive walking difficulties. Complicating neurological or extraneurological features may be present.
Case Report: We describe a 19-year-old male who was referred because of an action tremor of the hands; he later developed walking difficulties. Callosal atrophy
was present on his cerebral magnetic resonance imaging scan, prompting genetic testing for SPG11, which revealed homozygous mutations.
Discussion: The clinical features, differential diagnosis and management of SPG11, the most common form of autosomal recessive complicated HSP with a thin
corpus callosum are discussed.
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Introduction
Here, we describe a case of hereditary spastic paraplegia (HSP) with
tremor as the presenting feature. HSPs are a clinically and genetically
heterogeneous group of diseases, which typically present with slowly
progressive lower-extremity weakness and spasticity, causing progres-
sive walking difficulties.1,2 Additional bladder dysfunction and mild
sensory signs may be present. In contrast to these ‘‘pure’’ forms,
‘‘complicated’’ variants with additional features occur, which may
include seizures, dementia, amyotrophy, or extrapyramidal dysfunc-
tion. To date, at least 48 different subtypes of HSP have been
recognized. Here we present a case of SPG11 due to mutations in the
spatacsin gene, a major cause of complex phenotypes. The presence of a
thin corpus callosum is characteristic and its finding should be a red
flag.
Case report
This 19-year-old right-handed male was born after an uneventful
pregnancy. He reached his early milestones for standing, walking, and
speech slightly late; he was a slow learner in school but passed several
exams and went on to a higher education college. He had no problems
competing with his peers in sports. His problems began at age 14,
when he noted a tremor of the hands, so that he required a scribe for
his school exams.
His past medical history was unremarkable. He did not smoke or
drink alcohol. His parents had moved to the United Kingdom from
Kenya only a few years earlier. There was no history of tremor or
other movement disorder in the family; however, one distant paternal
cousin was said to have some form of spastic paraplegia.
When seen by a pediatric neurologist at age 16, there was an evident
mild action tremor. He had increased tone in his limbs, particularly
the legs, with brisk reflexes and flexor plantar responses. Power and
sensory examination were normal and there were no cerebellar signs.
Although he was noted to have a slightly stiff gait, initially a diagnosis
of ‘‘anxiety related tremor’’ was made and propranolol prescribed.
However, 6 months later he developed leg pain and difficulty climbing
stairs. He noted problems getting on and off trains without holding a
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bar for support. He also complained of leg stiffness in the mornings
prompting further evaluation.
Routine bloods, thyroid function tests, and ceruloplasmin were
normal. Genetic testing for Huntington’s disease (HD), dentatorubral
pallidoluysian atrophy, and spinocerebellar ataxias were negative.
Magnetic resonance imaging (MRI) of the spine was normal; in
particular, there was no spinal cord compression or lesion. An MRI
scan of the brain was also reported to be normal, although on later
review this was found to contain a key diagnostic clue.
When he first presented to us at age 17 his symptoms had
progressed. The action tremor was intrusive, affecting both hands,
right more than left, and disturbing fine manual function (e.g. writing
and doing up buttons). His parents noted that he had become more
anxious and prone to laughter. His appetite was normal and there
were no bladder or bowel symptoms. On examination there was
emotional lability. He had a moderate dysarthria, but cranial nerve
examination, including fundi and eye movements, was otherwise
normal. There were no abnormal signs in the upper limbs, except mild
dysdiadochkinesia. In particular, there was no tremor evident at rest,
posture, or during intention, but mild tremor was present when trying
to pick up change, open a bottle, or draw (Figure 1). In the lower
limbs, there was spastic paraparesis with increased tone, very brisk
reflexes, clonus at both ankles and extensor plantar responses. He wore
foot splints because of bilateral upper motor neuron foot drop. There
was no sensory deficit. His gait was narrow-based and there was a
tendency to drag his legs.
Propanolol 80 mg/day proved unhelpful for this intermittent
tremor. Baclofen 10 mg twice daily, however, relieved his muscle
spasms.
His previous imaging studies were reviewed and the corpus callosum
was noted to be abnormally thin (Figure 2). This prompted genetic
testing for SPG11, which revealed a homozygous c.5769delT spatacsin
mutation, resulting in p.S1923RfsX1950 with a premature stop at
codon 1950.
Discussion
HSPs are a clinically and genetically heterogeneous group of
neurological diseases. In practice ‘‘pure’’ manifestations are distin-
guished from ‘‘complicated’’ HSP forms, as the latter have additional
neurological or extraneurological features, including mental retarda-
tion, dysarthria, ataxia, peripheral neuropathy, or muscle atrophy.1
Extrapyramidal features as presenting or main feature are rare.
Inheritance of HSPs may be autosomal dominant, autosomal recessive,
or X-linked. However, most cases follow an autosomal dominant
pattern with SPG4 being most frequent, accounting for ,40% of
dominant HSPs. Among the autosomal recessive forms, mutations in
the spatacsin gene on chromosome 15q (SPG11, MIM610844)) are a
major cause of complex phenotypes, particularly when atrophy of the
corpus callosum is also present. Thus, in one study, the overall
frequency of SPG11 among patients with autosomal recessive early-
onset complicated HSP was 14%, but this was considerably higher in
patients with a thin corpus callosum (42%).3
Onset of SPG11 is early (during infancy or adolescence; age range
1–31 years),4 in line with our case. Progressive leg stiffness and learning
disabilities are the commonest symptoms at onset. Although our
patient had slightly delayed milestones, he presented with tremor,
which was followed by the development of leg stiffness and walking
difficulty. Patients may develop dysarthria, cerebellar ataxia, urinary
incontinence, or ophthalmological symptoms, including macular
degeneration, strabismus, or cataract. Peripheral neuropathy of the
axonal motor or sensorimotor type occur later in the disease course.
However, with identification of the gene, unusual phenotypes are
increasingly recognized and include a juvenile, slowly progressive form
of motor neuron disease associated with long-term survival,5 but not
cognitive impairment and a thin corpus callosum (TCC). A predo-
minantly parkinsonian phenotpye has also been reported recently.6,7
Our patient was referred to us because of tremor, which is a rare
presenting sign (seen in one of 37 gene-proven cases8). There were no
signs of parkinsonism in our patient.
However, while the clinical presentation of SPG11 can be complex
and overlaps with cerebellar ataxias, leukodystrophies, and other
disorders, certain features are usually not present in pure or com-
plicated HSPs and should make the clinician suspicious of an alter-
native diagnosis. This includes profound involvement of the upper
extremity or bulbar muscles, or diurnal fluctuations and dopa
responsiveness (as seen in dopa-responsive dystonia).
Thinning of the corpus callosum and in most cases periventricular
white matter alterations on MRI are characteristic of SPG11.9 This
finding prompted us to perform molecular testing for SPG11 in our
case. However, a thin corpus callosum may also occur in other
subforms of HSP, including SPG15 (spastizin, 14q22), SPG21
(maspardin, 15q22), SPG32 (14q12), SPG47 (AP4B1, 1p13) and
HSP-TCC with epilepsy (8p12) and occasionally in SPG4 (SPAST,
Figure 1. Ataxic-Tremor in a Spiral Drawing. A spiral drawn by the
patient when aged 17 years, showing mild ataxic (wavy rather than saw-tooth) type
action tremor.
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2p22) and SPG7 (paraplegin, 16q24). Molecular testing can determine
the underlying HSP form for those with known gene defects. The
spatacsin gene (SPG11) has 40 exons and encodes a protein of 2443
amino acids of unknown function, which is widely expressed in the
adult cerebellum, cerebral cortex, hippocampus, and pineal gland.10
The mutation identified in our case has previously been reported.11
Neuropathologically, SPG11 is characterized by ‘‘dying-back’’
axonal degeneration, maximal at the distal ends of the corticospinal
tracts.1,2 Mild loss of anterior horn cells may occur. Demyelination, if
present, is consistent with the degree of axonal degeneration. Atrophy
may also affect the brainstem, cerebellum, and deep gray matter,
whereas the basal ganglia and spinal cord are usually spared. The
pathophysiological underpinnings of tremor in SPG11 may include
cerebellar dysfunction and neuropathy.
The treatment of HSPs remains symptomatic and should be tailored
to the individual symptoms, for example baclofen can alleviate
spasticity. Patients may benefit from a multidisciplinary approach that
includes physiotherapy, speech therapy, and occupational therapy.
Genetic counseling should be offered and prenatal testing may be
available for families in which a disease-causing mutation has been
detected.
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Figure 2. MR Brain Scan Showing a Thin Corpus Callosum. Sagittal
brain magnetic resonance imaging of the patients with an SPG11 mutation
demonstrating a thin corpus callosum (arrowed), a useful clue to this diagnosis
(left, sagittal T1; center, axial T2, right, coronal T1 gradient echo).
SPG11 Presenting with Tremor Schneider SA, Mummery CJ, Mehrabian M, et al.
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org
The Center for Digital Research and Scholarship
Columbia University Libraries/Information Services3
